{"disease":{"id":"small-for-size-syndrome","name":"small for size syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06974344","title":"Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial)","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":80,"lead_sponsor_name":"King Faisal Specialist Hospital & Research Center","has_results":false},{"nct_id":"NCT05459883","title":"Splenic Artery Ligation and Portocaval Shunt in Small-for-size Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Aretaieion University Hospital","has_results":false},{"nct_id":"NCT07276568","title":"Safety, Tolerability, and Preliminary Efficacy of Hepatocyte-like Cell Injection for the Prevention and Treatment of Small-for-Size Syndrome","phase":"EARLY_PHASE1","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":12,"lead_sponsor_name":"Zhi-Jun Zhu","has_results":false},{"nct_id":"NCT07312864","title":"Safety and Tolerability Study of a Novel Bioartificial Liver in Liver Failure and Small-for-Size Syndrome","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}